Aberrant splicing events of CELF1 can lead to the production of abnormal isoforms, contributing to the translational activation of genes that drive epithelial–mesenchymal transition (EMT) and, consequently, tumor progression (Chaudhury et al., 2016). The gene discussed is CELF1; the disease is neoplasm.